Validation of Plasma Proneurotensin as a Novel Biomarker for the Prediction of Incident Breast Cancer

被引:17
作者
Melander, Olle [1 ,3 ,6 ]
Belting, Mattias [2 ,5 ,8 ]
Manjer, Jonas [1 ,4 ,7 ]
Maisel, Alan S. [9 ]
Hedblad, Bo [1 ,3 ,6 ]
Engstroem, Gunnar [1 ]
Nilsson, Peter [1 ,3 ,6 ]
Struck, Joachim [10 ]
Hartmann, Oliver [10 ]
Bergmann, Andreas [10 ,11 ]
Orho-Melander, Marju [1 ]
机构
[1] Lund Univ, Dept Clin Sci, Malmo, Sweden
[2] Lund Univ, Sect Oncol, Lund, Sweden
[3] Skane Univ Hosp, Ctr Emergency Med, Lund, Sweden
[4] Skane Univ Hosp, Dept Surg, Lund, Sweden
[5] Skane Univ Hosp, Dept Oncol, Lund, Sweden
[6] Skane Univ Hosp, Ctr Emergency Med, Malmo, Sweden
[7] Skane Univ Hosp, Dept Surg, Malmo, Sweden
[8] Skane Univ Hosp, Dept Oncol, Malmo, Sweden
[9] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA
[10] Sphingotec GmbH, Hennigsdorf, Germany
[11] Waltraut Bergmann Fdn, Hohen Neuendorf, Germany
基金
欧洲研究理事会; 瑞典研究理事会;
关键词
NEUROTENSIN; PROGRESSION; MORTALITY; RECEPTOR; PEPTIDE; TISSUE;
D O I
10.1158/1055-9965.EPI-13-1200
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: High fasting plasma proneurotensin concentration was associated with the development of breast cancer in the Malmo Diet and Cancer Study (MDCS). Here, we aimed at replicating the initial finding in an independent second cohort. Methods: The Malmo Preventive Project (MPP) is a population study and comprised 18,240 subjects when examined in 2002-2006. Of women without history of breast cancer at examination, we included all who developed breast cancer during follow-up (n = 130) until December 31, 2010, and a random sample of women without breast cancer until the end of follow-up (n = 1,439) for baseline plasma proneurotensin assessment (mean age, 70.0 +/- 4.4 years). Proneurotensin was measured in fasting plasma samples and was related to the risk of later breast cancer development using multivariate logistic regression. Results: Proneurotensin [odds ratio (OR) per standard deviation (SD) increment of LN-transformed proneurotensin] was significantly related to incident breast cancer [OR, 2.09; 95% confidence interval (CI), 1.79-2.44; P < 0.001; adjusted for age, body mass index (BMI), smoking, and hormone replacement therapy]. The effect estimate in the MPP was larger than in the discovery cohort (MDCS), with the main difference between the two cohorts being that women of the MPP study were on the average about 10 years older and follow-up time was shorter than that of the MDCS. Conclusion: As initially found in the MDCS, fasting plasma proneurotensin was significantly associated with the development of breast cancer in the MPP study as well. Impact: Measurement of plasma proneurotensin warrants further investigation as a blood-based marker for early breast cancer detection. (C) 2014 AACR.
引用
收藏
页码:1672 / 1676
页数:5
相关论文
共 19 条
[1]   Cardiovascular risk groups and mortality in an urban Swedish male population: The Malmo Preventive Project [J].
Berglund, G ;
Eriksson, KF ;
Israelsson, B ;
Kjellstrom, T ;
Lindgarde, F ;
Mattiasson, I ;
Nilsson, JA ;
Stavenow, L .
JOURNAL OF INTERNAL MEDICINE, 1996, 239 (06) :489-497
[2]   Adipose tissue and breast cancer progression: A link between metabolism and cancer [J].
Bertolini, Francesco .
BREAST, 2013, 22 :S48-S49
[3]  
CARRAWAY R, 1973, J BIOL CHEM, V248, P6854
[4]   Peripheral and Central Administration of Xenin and Neurotensin Suppress Food Intake in Rodents [J].
Cooke, Jennifer H. ;
Patterson, Michael ;
Patel, Sejal R. ;
Smith, Kirsty L. ;
Ghatei, Mohammad A. ;
Bloom, Stephen R. ;
Murphy, Kevin G. .
OBESITY, 2009, 17 (06) :1135-1143
[5]   The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers [J].
Dupouy, Sandra ;
Mourra, Najat ;
Doan, Van Kien ;
Gompel, Anne ;
Alifano, Marco ;
Forgez, Patricia .
BIOCHIMIE, 2011, 93 (09) :1369-1378
[6]   The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression [J].
Dupouy, Sandra ;
Viardot-Foucault, Veronique ;
Alifano, Marco ;
Souaze, Frederique ;
Plu-Bureau, Genevieve ;
Chaouat, Marc ;
Lavaur, Anne ;
Hugol, Danielle ;
Gespach, Christian ;
Gompel, Anne ;
Forgez, Patricia .
PLOS ONE, 2009, 4 (01)
[7]   Proneurotensin 1-117, a stable neurotensin precursor fragment identified in human circulation [J].
Ernst, A. ;
Hellmich, S. ;
Bergmann, A. .
PEPTIDES, 2006, 27 (07) :1787-1793
[8]   Neurotensin and growth of normal and neoplastic tissues [J].
Evers, B. Mark .
PEPTIDES, 2006, 27 (10) :2424-2433
[9]   Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project) [J].
Fedorowski, Artur ;
Stavenow, Lars ;
Hedblad, Bo ;
Berglund, Goran ;
Nilsson, Peter M. ;
Melander, Olle .
EUROPEAN HEART JOURNAL, 2010, 31 (01) :85-91
[10]  
Garne JP, 1996, INVASIVE BREAST CANC